2021
DOI: 10.1016/j.preghy.2020.11.013
|View full text |Cite
|
Sign up to set email alerts
|

Validation of the fullPIERS model for prediction of adverse outcomes in preeclampsia at a referral center

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
1
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 12 publications
1
1
0
Order By: Relevance
“…We demonstrated that the fullPIERS model has good predictive power for maternal adverse events in pre‐eclampsia (AUC‐ROC 0.843, 95% CI 0.789–0.897) (Figure 3). This corroborated the results of Akkermans et al 18 and others, who not only externally validated the model's performance, but also reported its usefulness in cases of early‐onset pre‐eclampsia 17–24 . Notwithstanding, some of these studies were designed for high‐income countries.…”
Section: Discussionsupporting
confidence: 87%
See 1 more Smart Citation
“…We demonstrated that the fullPIERS model has good predictive power for maternal adverse events in pre‐eclampsia (AUC‐ROC 0.843, 95% CI 0.789–0.897) (Figure 3). This corroborated the results of Akkermans et al 18 and others, who not only externally validated the model's performance, but also reported its usefulness in cases of early‐onset pre‐eclampsia 17–24 . Notwithstanding, some of these studies were designed for high‐income countries.…”
Section: Discussionsupporting
confidence: 87%
“…This corroborated the results of Akkermans et al 18 and others, who not only externally validated the model's performance, but also reported its usefulness in cases of early-onset pre-eclampsia. [17][18][19][20][21][22][23][24] Notwithstanding, some of these studies were designed for high-income countries.…”
Section: Discussionmentioning
confidence: 99%